Ensure seamless EU marketing authorization with Zenovel’s expert Environmental Risk Assessment (ERA) services. We guide pharmaceutical companies through the complete EMA framework—from Phase I exposure estimation and Phase II fate testing (Tier A/B) to PBT screening, literature justification, and multi-market PEC harmonization. Avoid submission delays and bridge your clinical and CMC data with our specialized regulatory support.